XML 51 R42.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Entities and Acquisitions - Pro Forma Information (Details) - Entasis Therapeutics Holdings Inc - La Jolla Pharmaceutical Company - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Business Acquisition [Line Items]    
Revenue $ 118,764 $ 219,247
Net income 17,642 50,218
Net income (loss) attributable to Innoviva stockholders $ (5,258) $ 8,297